4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:Chromogenix
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Diapharma/Chromogenix S-2251™/S820332/小瓶/25mg
商品详细Diapharma/Chromogenix S-2251™/S820332/小瓶/25mg
Diapharma/Chromogenix S-2251™/S820332/小瓶/25mg
Diapharma/Chromogenix S-2251™/S820332/小瓶/25mg
商品编号: S820332
品牌: Diapharma
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Description:

ChromogenixS-2251™isachromogenicsubstrateforplasminandstreptokinase-activatedplasminogen.Thesubstratehasbeenusedforthedeterminationof:

  • Antiplasmininplasma
  • Plasminogeninplasma

Composition:

EachvialcontainschromogenicsubstrateS-2251™,25mgandmannitol60mgasabulkingagent.StABIlity:Substance:Stableuntilexpirydateifstoredat2-8°C.Avoidexposuretolight.Thesubstanceishygroscopicandshouldbestoreddry.Solution:3mmol/LinH2Oisstableforatleast6monthsat2-8°C.Contaminationbymicroorganismsmaycausehydrolysis.

Chemicalname:H-D-Valyl-L-leucyl-L-lysinep-Nitroanilinedihydrochloride

Formula:H-D-Val-Leu-Lys-pNA·2HCl

Mol.wt:551.6

chromogenix chromogenic substrate assay test kit

PlasminogenandPlasminIUandEnzymeActivity:

Plasminogen(MW:92Kda)isthezymogenformofplasmin(83KDa).

Theactivationofplasminogenisaccomplishedbyt-PA,urokinaseorstreptokinase.

Itisnotthepurposeofthistexttodescribethemechanismsofactivationofplasminogenanditsinhibition,butitisimportanttounderlinethattheycanaffectthereactionoftheactiveenzymewithchromogenicsubstrates,caseinorfibrin.

FormoreinformationrefertoGaffney(1).

1mlofnormalplasmacontainsabout180µgor2nmolofplasminogen.Theactivityofplasminogencanbeexpressedincaseinunits(CU)e.g.forexampletoSgourisetal.(2).

Friberger(3)foundthattheamountofplasminogenin1mlofnormalplasmacorrespondsto3.8CU,asdeterminedbythechromogenicmethoddescribed(streptokinaseactivatedplasminogen).

TheChromogenixplasminogenreagentwhenactivatedwithstreptokinaseshowsanactivityof 7.3nkatchromogenicsubstrateS-2251™perCU.

In1983Friberger(4)reportedthat1µgofplasmincorrespondsto0.20nkatchromogenicsubstrateS-2251™,orto0.024CUorto0.028CTA-U.

In1975,thefirststandardforplasminwasestablished(5)andtheinternationalunitwasdefinedequivalenttoCTA-U(5-6).

Thiscontainedapurifiedhumanplasminin50%glycerol.WhentestedbyFribergeretal.(7),itshowedaboutthesameactivityastheKabipreparationintermsofµmolofsubstratehydrolysedperminuteperunitofenzyme. Sincethenthedifferentaspectsofcaseinolytic,amidolyticandfibrinolyticactivityhavebeenexploredindetailsand,thediscrepancybetweenamidolyticandfibrinolyticactivityinreferencepreparationswasunderlinedasinthecaseofthe2ndInternationalReferencePreparationofplasminin1983(8).

Thecurrent3rdInternationalStandardforplasmin,97/536wasestablishedin1998,andtheresultspresentedattheFibrinolysisSubcommitteeoftheScientificandStandardizationCommitteeoftheInternationalSocietyofThrombosisandHaemostasis(Ljubljana,Slovenia,June1998).The2ndInternationalReferencePreparationwasusedasreferencematerialandachromogenicassaywasthemethodused.ThereisnoestablishedWHOstandardforplasminogen,buttheNationalInstituteforBIOLOGicalStandardsandControl,establishedtheIstBritishReferencePreparation,78/646(9).

ItisapreparationofGlu-plasminogen,assayedbyfibrinolyticandchromogenicmethodsagainstthe2ndInternationalStandardforplasmin.Completeactivationofplasminogenwasachievedbybothurokinaseorstreptokinaseandtheactivitywascomparabletothatofthereferencepreparationofplasmin.

  1. GaffneyPJ.
    Standardizationofplasminogenassays.Haemostasis18Suppl.1,47-60(1988).
  2. SgourisJTetal.
    Thepreparationofhumanfibrinolysin(plasmin).VoxSang5,357-376(1960).
  3. FribergerPandKnosM.
    Plasminogenactivationinnormalplasma.In:Chromogenicpeptidesubstrates,Eds,ScullyMFandKakkarVV,ChurchillLivingstone,128-140(1979).
  4. FribergerPetal.
    Syntheticpeptidesubstrateassaysandfibrinolysisandtheirapplicationonautomates.In:SeminarsinThrombosisandHaemostasis,Vol.9,281-300(1983).
  5. KirkwoodTBetal.
    Astandardforhumanplasmin.
    ThrombDiathHaemorrh34,20-30(1975).
  6. 28thReport,WHOExpertCommitteeonBiologicalStandardization.WHOTechRepSerNo610;1977,pp13.
  7. FribergerPetal.
    Anewspecificsubstrateforthedeterminationofplasmin.In:Chromogenicpeptidesubstrates,Eds,ScullyMFandKakkarVV,ChurchillLivingstone,121-127(1979).
  8. GaffneyPJandMussettMV.
    Internationalcollaborativestudyfortheestablishmentofthesecondinternationalreferencepreparationofplasmin.ThrombHaemost50,645-649(1983).
  9. GaffneyPJandCurtisAD.
    Theestablishmentofastandardforplasminogen.ThrombHaemost51,376-378(1984).
品牌介绍
Diapharma使命宣言位于俄亥俄州西切斯特的Difarma Group,Inc.在诊断和研究领域销售止血、血栓形成、血小板功能测试、仪器和凋亡产品,并提供强大的技术能力和经验,以确保满足或超过客户的期望。地黄止血显色凝块酶联免疫吸附试验试剂盒历史1997年1月1日,由俄亥俄州富兰克林市的Pharmacia Hepar,Inc.成立,最初是Chromogenix基质和分析的独家美国和加拿大经销商。四分之一个多世纪前,Chromogenix开发了第一个显色底物技术,其前身是Kabi Diagnostica。卡比后来与法玛西亚合并。希帕玛目前的一些员工在法玛西亚肝素制造厂的显色部门工作。1998年,夏帕玛搬到了俄亥俄州的西切斯特,至今仍在那里。多年来,迪法玛扩大了其产品线,包括各种止血、细胞死亡、血小板功能、生态毒理学、化验、试剂、抗体和高级制造商的仪器。2017年,夏帕玛庆祝了20年的成功